News

IntriCon Corporation, a designer, developer, manufacturer and distributor of miniature and micro-miniature body-worn devices, announced it has received 510(k) marketing clearance from the U.S. Food and Drug Administration (FDA), for the...

ARCA biopharma, Inc., a biopharmaceutical company developing genetically-targeted therapies for atrial fibrillation and other cardiovascular diseases, announced that two Gencaro (bucindolol hydrochloride) abstracts have been selected for oral...

AmbiCom Holdings, Inc., a leader in the development of wireless products for medical equipment suppliers, announced that it has signed an agreement with a major medical device manufacturer to jointly develop a Wi-Fi card application for its...

St. Jude Medical, Inc. announced that the first patient was enrolled in the EAST (Early comprehensive Atrial fibrillation Stroke prevention Trial) clinical trial. The investigator-initiated study seeks to determine whether an early,...

Results from a large, United States based cohort study show that current smokers double their risk of developing atrial fibrillation (AF) compared to people who have never smoked, after more than 13 years of follow-up. The study, published in...

Medtronic, Inc. announced U.S. Food and Drug Administration (FDA) approval for its Investigational Device Exemption (IDE) application and pivotal clinical trial protocol to begin evaluating the Advisa DR MRI™ SureScan® pacing system. FDA...

Magnetecs Corporation, a designer and manufacturer of robotic catheterization control systems for minimally invasive surgical procedures, reported that a paper entitled “Dynamically Shaped Magnetic Fields: Initial Animal Validation of a New...

The Mount Sinai Medical Center has become the first hospital on the east coast to perform a cardiac ablation procedure using the ThermoCool SmartTouch Contact Force-Sensing Catheter for the treatment of symptomatic, paroxysmal atrial...

Merck, known as MSD outside the United States and Canada, and Astellas US LLC, the U.S. subsidiary of Astellas Pharma Inc., announced that they have entered into an agreement under which Merck, through a subsidiary, will acquire the exclusive...

As the number of interventional procedures to diagnose and treat patients increases worldwide, and the procedures grow in complexity and length, exposure to radiation is a growing concern for both clinicians and patients. Interventional...